Altria Group reported a double beat in Q4, driven by strong growth from its on! brand. Read more to see why I remain bullish ...
The cigarette giant beat expectations for the fourth quarter by a slender margin, but saw growth in its smoke-free product segments.
Q4 2024 Earnings Call Transcript January 30, 2025 9:00 AM ETCompany ParticipantsMac Livingston - Vice President of ...
The main reason Altria stock pulled back was its guidance came up short. Management said adjusted earnings per share would grow 2% to 5%, reaching $5.22 to $5.37, which compares to the analyst ...
RICHMOND, Va. - Altria Group , Inc. (NYSE: NYSE:MO), the $89 billion tobacco giant, today announced its financial results for the fourth quarter of 2024 and provided its full-year earnings guidance ...
Altria , the maker of Marlboro cigarettes, has placed under review its 2028 goals for selling alternatives to smoking on the ...
The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application ...
The Associated Press - Business News on MSN14d
FDA approves Zyn nicotine pouches, citing health benefits for adult smokersFederal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback